Oppenhoff advises EIC Fund on investment in biotech start-up CO2BioClean

Oppenhoff has once again comprehensively advised the EIC Fund on its investments in Germany. This time, the EIC Fund invested in the biotech start-up CO2BioClean GmbH.

The EIC Fund is the special fund of the European Innovation Council and thus the key investment vehicle of the European Commission. Its purpose is to implement the European Commission's EIC Accelerator Programme, which supports innovative and sustainable European growth companies. The EIC (European Innovation Council) was established under the pilot project "Horizon 2020 - the Framework Programme for Research and Innovation" and was successfully continued in 2021 with the launch of the "Horizon Europe Programme". With a term extending from 2021 to 2027 and a total budget of up to 95.5 billion euros, it is one of the largest funding programmes for research and innovation worldwide. In 2022, the EIC Fund was the largest European deeptech VC fund with 71 investments.

CO2BioClean GmbH currently offers the only market-ready process for producing Co2-based biopolymers and has already concluded initial cooperation agreements with industrial partners such as Nippon Gases and Procter & Gamble. The financing round had a total volume of around 3.6 million euros.

The Oppenhoff team led by Dr Peter Etzbach included Dr Jonas Weise (both Corporate/M&A), Dr Fee Mäder and Dr Patric Mau (both IP) and Dr Johannes Kaesbach (Employment).

Oppenhoff regularly advises companies in the venture capital environment, most recently for example the EIC Fund on its investment in the tech start-up enote, the investment in the tech start-up Nyris as well as on numerous other investments in German start-ups, SellerX on the acquisition of KW-Commerce, BeyondBuild on the strategic merger of spaceOS and Equiem Holdings and the ND Group B.V. in a financing round of over 30 million euros for e.GO Mobile.

Back to list